Obama Submits Science-Boosting Budget

But some critics say the President relies too heavily on mandatory funding to support the biomedical research enterprise.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, REVISORWEBPresident Barack Obama has finalized his FY2017 federal budget proposal and, at first glance, science seems to fare alright in the plan. But the President relies on mandatory funds, which historically haven’t had an easy path through Congress, to boost budgets at the National Institutes of Health (NIH) and other federal science agencies. Under the proposed budget, the NIH would get an $825 million boost, raising its annual budget to $33.1 billion; the National Science Foundation would get a $900 million increase; and the Department of Energy’s Office of Science would get a $325 million boost. Several big science initiatives also stand to get more funding: a $45 million boost to the BRAIN Initiative, $300 million for the White House’s precision medicine program, and $755 million to launch the “cancer moonshot” Obama announced in his last State of the Union address.

But much of these funding increases depend on Congress passing mandatory funding allocations, which has been a sticky proposition in years past. If that mandatory funding doesn’t make it through the legislative sausage grinder, the NIH is set to have its budget cut by $1 billion in 2017, according to an analysis by the American Association for the Advancement of Science that was cited by The Chronicle of Higher Education.

“While we appreciate that President Obama’s overall goal is to increase funding for biomedical research, we are disappointed his proposed budget would actually decrease the baseline funding level for the National Institutes of Health (NIH) in FY2017,” advocacy group United for Medical Research said in a statement. “It is essential that funding for the NIH ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo